More than 780K doses of monkeypox vaccine available Friday; US orders 5.5M for 2023



Amid concerns the government has not responded quickly enough to the nation’s rapidly spreading monkeypox outbreak, the Biden administration announced more than 780,000 doses of vaccine will be available Friday. 

Those doses will add to the 300,000 doses distributed this month, bringing the total to 1.1 million. 

The federal government also ordered 5.5 million doses be made from supplies in manufacturer storage, which will be ready in 2023. 

There is enough material in storage for 11.1 million more doses, if needed, according to Jennifer McQuiston, the deputy director of the Division of High Consequence Pathogens and Pathology at the Centers for Disease Control and Prevention. 

“We are currently continuing to work with our supplier to identify opportunities to further expand supply and accelerate availability of this critical vaccine,” she said Thursday.

Addressing myths about monkeypox: A look at symptoms, treatment and other common questions

Closer look: Rising reports of monkeypox cases in US and around the world raise concern

Two vaccines can be used against monkeypox but only one – called Jynneos – is being widely prescribed during this outbreak. A full course of the vaccine includes two shots, the second at least one month after the first.

The other, ACAM2000, has more side effects and can’t be administered to people who have a weakened immune system, have certain skin conditions or are pregnant. 

Health officials also have expanded testing capacity. Monkeypox tests were first concentrated at the CDC, but commercial labs now offer tens of thousands of tests a day, growing from about 6,000 weekly tests in mid-May to about 80,000, said Health and Human Services Secretary Xavier Becerra.


Monkeypox survivor says attempts at getting vaccine failed

Monkeypox was declared a “public health emergency” as officials around the U.S. release more vaccines in order to prevent the spread of the virus.

Patrick Colson-Price, USA TODAY

An antiviral called tecovirimat, sold under the brand name TPOXX, has been approved to treat smallpox and is now being used to treat people with monkeypox. TPOXX can prevent infection if given before or within four days of exposure, and prevents severe disease if given up to two weeks after someone is exposed to the virus.

Becerra said fewer than 10,000 Americans have received treatment, but said more than 1.7 million doses of the treatment available in the national stockpile.

“Our goal is pretty straightforward: Stay head of the virus and end this outbreak,” he said. “At HHS, we’re doing everything we can in that regard.”  

As of Wednesday, over 20,000 cases of monkeypox have been detected globally in 77 countries, McQuiston said. The U.S. has about 4,600 reported cases. Health officials said they’re still weighing whether declare monkeypox a public health emergency, which would free up more resources.

In the meantime, they urged Americans to remain vigilant and stay informed to prevent further spread of the virus.

“Every American should pay attention on monkeypox,” Becerra said. “Monkeypox is not COVID but it is contagious, it is painful, and it can be dangerous.”

Contributing: Karen Weintraub, USA TODAY. Follow Adrianna Rodriguez on Twitter: @AdriannaUSAT. 

Health and patient safety coverage at USA TODAY is made possible in part by a grant from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare. The Masimo Foundation does not provide editorial input.

Read More

Affiliate disclosure: The links contained in this product review may result in a small commission if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products.

Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease.


Please enter your comment!
Please enter your name here